Real world study on the efficacy and tolerability of ixabepilone monotherapy vs. combination therapy with capecitabine in metastatic breast cancer patients (MBC)

被引：0
|
作者：
Hyder, Tara [1 ]
Rosenzweig, Margaret [1 ]
Brufsky, Adam M. [1 ]
机构：
[1] Magee Womens Hosp, Pittsburgh, PA USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS13-47
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy of repaglinide vs. nateglinide: As monotherapy or metformin combination therapy
    Saad, MF
    Hale, P
    Khutoryansky, N
    DIABETES, 2002, 51 : A133 - A133
  • [42] Phase III Trial of Sunitinib in Combination With Capecitabine Versus Capecitabine Monotherapy for the Treatment of Patients With Pretreated Metastatic Breast Cancer
    Crown, John P.
    Dieras, Veronique
    Staroslawska, Elzbieta
    Yardley, Denise A.
    Bachelot, Thomas
    Davidson, Neville
    Wildiers, Hans
    Fasching, Peter A.
    Capitain, Olivier
    Ramos, Manuel
    Greil, Richard
    Cognetti, Francesco
    Fountzilas, George
    Blasinska-Morawiec, Maria
    Liedtke, Cornelia
    Kreienberg, Rolf
    Miller, Wilson H., Jr.
    Tassell, Vanessa
    Huang, Xin
    Paolini, Jolanda
    Kern, Kenneth A.
    Romieu, Gilles
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (23) : 2870 - +
  • [43] The combination of capecitabine and cyclophosphamide for metastatic breast cancer patients
    Suzuki, M.
    Kimijima, I.
    Ishii, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [44] A Real-World Efficacy of Nab-Paclitaxel Monotherapy in Metastatic Breast Cancer
    Kim, Jung Sun
    Suh, Koung Jin
    Lee, Dae-Won
    Woo, Go-Un
    Kim, Miso
    Kim, Se Hyun
    Ryu, Han Suk
    Lee, Kyung-Hun
    Kim, Tae-Yong
    Han, Sae-Won
    Park, So Yeon
    Park, In Ae
    Kim, Jee Hyun
    Im, Seock-Ah
    CANCER RESEARCH AND TREATMENT, 2022, 54 (02): : 488 - 496
  • [45] Ixabepilone plus capecitabine vs capecitabine in patients with metastatic breast cancer receiving ixabepilone in the first line setting: a pooled analysis from two phase III studies.
    Vahdat, L.
    Fein, L. E.
    Karwal, M. W.
    Campone, M.
    Peck, R.
    Mukhopadhyay, P.
    Jassem, J.
    CANCER RESEARCH, 2009, 69 (02) : 382S - 383S
  • [46] Capecitabine (X) and taxanes in patients (pts) with anthracycline-pretreated metastatic breast cancer (MBC): sequential vs. combined therapy results from the Mexican Oncology Study Group.
    Torrecillas, L
    Soto, C
    Cervantes, G
    Benitez, H
    Acosta, A
    Cortes, P
    Gonzalez, F
    Zamora, R
    Rodriguez, G
    Silva, A
    Leoner, C
    Sauza, F
    Suarez, T
    Tokunaga, J
    Erazo, A
    Talavera, J
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S200 - S200
  • [47] All oral combination of vinorelbine and capecitabine as a first line treatment in patients (pts) with metastatic breast cancer (MBC)
    Shehata, S.
    Khalaf, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [48] Capecitabine maintenance therapy following docetaxel/capecitabine combination treatment. in patients with metastatic breast cancer
    Surmeli, Zeki Gokhan
    Varol, Umut
    Cakar, Burcu
    Degirmenci, Mustafa
    Arslan, Cagatay
    Piskin, Gonul Demir
    Zengel, Baha
    Karaca, Burcak
    Sanli, Ulus Ali
    Uslu, Ruchan
    ONCOLOGY LETTERS, 2015, 10 (04) : 2598 - 2602
  • [49] Quality of life (QoL) improvements with capecitabine in patients with metastatic breast cancer (MBC)
    Segalla, J.
    Tosello, C.
    Ribeiro, R.
    Tessaro, S.
    Cabral, S.
    Perdicaris, M. R.
    Moura, G. L.
    Lago, S.
    Garicochea, B.
    Abdo, E.
    EJC SUPPLEMENTS, 2005, 3 (02): : 115 - 115
  • [50] Efficacy of Capecitabine (X) monotherapy in anthracycline-pretreated metastatic breast cancer (MBC): preliminary results of phase II study(Experienced in single institution)
    Kurnianda, Johan
    Haryadi, Achmad
    Aryandono, Teguh
    ANNALS OF ONCOLOGY, 2004, 15 : 41 - 41
12345